Clinical Trial Efficiencies
Clinical trials are an expensive component of the drug development process. Streamlining trials to reduce the time needed for testing or allowing companies or allowing better comparison of trial outcomes (like using agreed outcomes, simplifying age de-escalation steps, and coordinating ethical approval for multi-center trials) could lower costs for drug developers and may encourage R&D for global health. The European & Developing Countries Clinical Trials Partnership, for instance, supports multi-center trials, increasing efficiency of multiple trials and building capacity of trial sites in the developing world.